Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 May 15;348(Pt 1):63–69.

Exon-skipping in BCR/ABL is induced by ABL exon 2.

B D Lichty 1, S Kamel-Reid 1
PMCID: PMC1221036  PMID: 10794714

Abstract

The BCR/ABL fusion gene is pathognomonic for chronic myelogenous leukaemia (CML). We have previously reported alternative splicing of BCR/ABL, as indicated by the detection of both p190- and p210-encoding transcripts, in about 60% of CML patient samples. These exon-skipping events involved the joining of ABL exon 2 to variable upstream BCR exons. Similarly, ABL exon 2 is alternatively spliced to either of two upstream ABL exons (1a or 1b) in c-ABL. We have constructed BCR and BCR/ABL minigenes to study this phenomenon in more detail. These constructs were transfected into various cell types and splicing was assessed by reverse transcriptase PCR. Whereas the basic BCR minigene expressed exon-inclusive transcripts only, insertion of genomic DNA spanning ABL exon 2 induced exon-skipping but only when expressed in the CML cell lines K562 and EM3. In this study we localized the required sequence element to ABL exon 2 itself. These results mimic the splicing phenotype displayed by most CML patients. We propose a model where a trans-factor present in some CML cells interacts with ABL exon 2 pre-mRNA to promote skipping of upstream BCR exons.

Full Text

The Full Text of this article is available as a PDF (200.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Neriah Y., Daley G. Q., Mes-Masson A. M., Witte O. N., Baltimore D. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science. 1986 Jul 11;233(4760):212–214. doi: 10.1126/science.3460176. [DOI] [PubMed] [Google Scholar]
  2. Biondi A., Rambaldi A., Rossi V., Elia L., Caslini C., Basso G., Battista R., Barbui T., Mandelli F., Masera G. Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood. 1993 Nov 15;82(10):2943–2947. [PubMed] [Google Scholar]
  3. Boise L. H., González-García M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nuñez G., Thompson C. B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993 Aug 27;74(4):597–608. doi: 10.1016/0092-8674(93)90508-n. [DOI] [PubMed] [Google Scholar]
  4. Carstens R. P., Eaton J. V., Krigman H. R., Walther P. J., Garcia-Blanco M. A. Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer. Oncogene. 1997 Dec 18;15(25):3059–3065. doi: 10.1038/sj.onc.1201498. [DOI] [PubMed] [Google Scholar]
  5. Castellanos A., Pintado B., Weruaga E., Arévalo R., López A., Orfao A., Sánchez-García I. A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood. 1997 Sep 15;90(6):2168–2174. [PubMed] [Google Scholar]
  6. Chan R. C., Black D. L. The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream. Mol Cell Biol. 1997 Aug;17(8):4667–4676. doi: 10.1128/mcb.17.8.4667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Costello R., Sainty D., Lecine P., Cusenier A., Mozziconacci M. J., Arnoulet C., Maraninchi D., Gastaut J. A., Imbert J., Lafage-Pochitaloff M. Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics. Leukemia. 1997 May;11(5):644–650. doi: 10.1038/sj.leu.2400629. [DOI] [PubMed] [Google Scholar]
  8. Cáceres J. F., Stamm S., Helfman D. M., Krainer A. R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science. 1994 Sep 16;265(5179):1706–1709. doi: 10.1126/science.8085156. [DOI] [PubMed] [Google Scholar]
  9. Groffen J., Stephenson J. R., Heisterkamp N., de Klein A., Bartram C. R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984 Jan;36(1):93–99. doi: 10.1016/0092-8674(84)90077-1. [DOI] [PubMed] [Google Scholar]
  10. Heisterkamp N., Jenster G., ten Hoeve J., Zovich D., Pattengale P. K., Groffen J. Acute leukaemia in bcr/abl transgenic mice. Nature. 1990 Mar 15;344(6263):251–253. doi: 10.1038/344251a0. [DOI] [PubMed] [Google Scholar]
  11. Hermans A., Heisterkamp N., von Linden M., van Baal S., Meijer D., van der Plas D., Wiedemann L. M., Groffen J., Bootsma D., Grosveld G. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell. 1987 Oct 9;51(1):33–40. doi: 10.1016/0092-8674(87)90007-9. [DOI] [PubMed] [Google Scholar]
  12. Honda H., Fujii T., Takatoku M., Mano H., Witte O. N., Yazaki Y., Hirai H. Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood. 1995 May 15;85(10):2853–2861. [PubMed] [Google Scholar]
  13. Honda H., Oda H., Suzuki T., Takahashi T., Witte O. N., Ozawa K., Ishikawa T., Yazaki Y., Hirai H. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias. Blood. 1998 Mar 15;91(6):2067–2075. [PubMed] [Google Scholar]
  14. Jiang Z. H., Zhang W. J., Rao Y., Wu J. Y. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9155–9160. doi: 10.1073/pnas.95.16.9155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kantarjian H. M., Deisseroth A., Kurzrock R., Estrov Z., Talpaz M. Chronic myelogenous leukemia: a concise update. Blood. 1993 Aug 1;82(3):691–703. [PubMed] [Google Scholar]
  16. Kim J., Lee K., Pelletier J. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties. Oncogene. 1998 Apr 16;16(15):1973–1979. doi: 10.1038/sj.onc.1201716. [DOI] [PubMed] [Google Scholar]
  17. Lichty B. D., Keating A., Callum J., Yee K., Croxford R., Corpus G., Nwachukwu B., Kim P., Guo J., Kamel-Reid S. Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia. Br J Haematol. 1998 Dec;103(3):711–715. doi: 10.1046/j.1365-2141.1998.01033.x. [DOI] [PubMed] [Google Scholar]
  18. Lin C. L., Bristol L. A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J. D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron. 1998 Mar;20(3):589–602. doi: 10.1016/s0896-6273(00)80997-6. [DOI] [PubMed] [Google Scholar]
  19. McKeown M. Alternative mRNA splicing. Annu Rev Cell Biol. 1992;8:133–155. doi: 10.1146/annurev.cb.08.110192.001025. [DOI] [PubMed] [Google Scholar]
  20. McLaughlin J., Chianese E., Witte O. N. Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol Cell Biol. 1989 May;9(5):1866–1874. doi: 10.1128/mcb.9.5.1866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McLaughlin J., Chianese E., Witte O. N. In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6558–6562. doi: 10.1073/pnas.84.18.6558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Melo J. V. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996 Oct 1;88(7):2375–2384. [PubMed] [Google Scholar]
  23. Mittre H., Leymarie P., Macro M., Leporrier M. A new case of chronic myeloid leukemia with c3/a2 BCR/ABL junction. Is it really a distinct disease? Blood. 1997 Jun 1;89(11):4239–4241. [PubMed] [Google Scholar]
  24. Modafferi E. F., Black D. L. A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon. Mol Cell Biol. 1997 Nov;17(11):6537–6545. doi: 10.1128/mcb.17.11.6537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Morris C. M., Heisterkamp N., Groffen J., Fitzgerald P. H. Entire ABL gene is joined with 5'-BCR in some patients with Philadelphia-positive leukemia. Blood. 1991 Aug 15;78(4):1078–1084. [PubMed] [Google Scholar]
  26. Muller A. J., Young J. C., Pendergast A. M., Pondel M., Landau N. R., Littman D. R., Witte O. N. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol. 1991 Apr;11(4):1785–1792. doi: 10.1128/mcb.11.4.1785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Noordzij M. A., van Steenbrugge G. J., Verkaik N. S., Schröder F. H., van der Kwast T. H. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin Cancer Res. 1997 May;3(5):805–815. [PubMed] [Google Scholar]
  28. Rio D. C. Splicing of pre-mRNA: mechanism, regulation and role in development. Curr Opin Genet Dev. 1993 Aug;3(4):574–584. doi: 10.1016/0959-437x(93)90093-5. [DOI] [PubMed] [Google Scholar]
  29. Romero P., Beran M., Shtalrid M., Andersson B., Talpaz M., Blick M. Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemia. Oncogene. 1989 Jan;4(1):93–98. [PubMed] [Google Scholar]
  30. Rowley J. D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973 Jun 1;243(5405):290–293. doi: 10.1038/243290a0. [DOI] [PubMed] [Google Scholar]
  31. Saglio G., Pane F., Gottardi E., Frigeri F., Buonaiuto M. R., Guerrasio A., de Micheli D., Parziale A., Fornaci M. N., Martinelli G. Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood. 1996 Feb 1;87(3):1075–1080. [PubMed] [Google Scholar]
  32. Saito H., Nakatsuru S., Inazawa J., Nishihira T., Park J. G., Nakamura Y. Frequent association of alternative splicing of NER, a nuclear hormone receptor gene in cancer tissues. Oncogene. 1997 Feb 6;14(5):617–621. doi: 10.1038/sj.onc.1200859. [DOI] [PubMed] [Google Scholar]
  33. Shah N. P., Witte O. N., Denny C. T. Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines. Mol Cell Biol. 1991 Apr;11(4):1854–1860. doi: 10.1128/mcb.11.4.1854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Shaham S., Horvitz H. R. An alternatively spliced C. elegans ced-4 RNA encodes a novel cell death inhibitor. Cell. 1996 Jul 26;86(2):201–208. doi: 10.1016/s0092-8674(00)80092-6. [DOI] [PubMed] [Google Scholar]
  35. Shtivelman E., Lifshitz B., Gale R. P., Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985 Jun 13;315(6020):550–554. doi: 10.1038/315550a0. [DOI] [PubMed] [Google Scholar]
  36. Shtivelman E., Lifshitz B., Gale R. P., Roe B. A., Canaani E. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell. 1986 Oct 24;47(2):277–284. doi: 10.1016/0092-8674(86)90450-2. [DOI] [PubMed] [Google Scholar]
  37. Silliman C. C., McGavran L., Wei Q., Miller L. A., Li S., Hunger S. P. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides. Leukemia. 1998 Sep;12(9):1404–1410. doi: 10.1038/sj.leu.2401109. [DOI] [PubMed] [Google Scholar]
  38. Staffa A., Acheson N. H., Cochrane A. Novel exonic elements that modulate splicing of the human fibronectin EDA exon. J Biol Chem. 1997 Dec 26;272(52):33394–33401. doi: 10.1074/jbc.272.52.33394. [DOI] [PubMed] [Google Scholar]
  39. Stewart M. J., Cox G., Reifel-Miller A., Kim S. Y., Westbrook C. A., Leibowitz D. S. A novel transcriptional suppressor located within a downstream intron of the BCR gene. J Biol Chem. 1994 Apr 8;269(14):10820–10829. [PubMed] [Google Scholar]
  40. Tian M., Maniatis T. A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA. Cell. 1993 Jul 16;74(1):105–114. doi: 10.1016/0092-8674(93)90298-5. [DOI] [PubMed] [Google Scholar]
  41. Voncken J. W., Griffiths S., Greaves M. F., Pattengale P. K., Heisterkamp N., Groffen J. Restricted oncogenicity of BCR/ABL p190 in transgenic mice. Cancer Res. 1992 Aug 15;52(16):4534–4539. [PubMed] [Google Scholar]
  42. Voncken J. W., Kaartinen V., Pattengale P. K., Germeraad W. T., Groffen J., Heisterkamp N. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood. 1995 Dec 15;86(12):4603–4611. [PubMed] [Google Scholar]
  43. Wada H., Mizutani S., Nishimura J., Usuki Y., Kohsaki M., Komai M., Kaneko H., Sakamoto S., Delia D., Kanamaru A. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. Cancer Res. 1995 Jul 15;55(14):3192–3196. [PubMed] [Google Scholar]
  44. Wu J. Y., Maniatis T. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell. 1993 Dec 17;75(6):1061–1070. doi: 10.1016/0092-8674(93)90316-i. [DOI] [PubMed] [Google Scholar]
  45. Zhu Q. S., Heisterkamp N., Groffen J. Unique organization of the human BCR gene promoter. Nucleic Acids Res. 1990 Dec 11;18(23):7119–7125. doi: 10.1093/nar/18.23.7119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. de Klein A., van Kessel A. G., Grosveld G., Bartram C. R., Hagemeijer A., Bootsma D., Spurr N. K., Heisterkamp N., Groffen J., Stephenson J. R. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature. 1982 Dec 23;300(5894):765–767. doi: 10.1038/300765a0. [DOI] [PubMed] [Google Scholar]
  47. van Dijk M. A., Floore A. N., Kloppenborg K. I., van 't Veer L. J. A functional assay in yeast for the human estrogen receptor displays wild-type and variant estrogen receptor messenger RNAs present in breast carcinoma. Cancer Res. 1997 Aug 15;57(16):3478–3485. [PubMed] [Google Scholar]
  48. van Rhee F., Hochhaus A., Lin F., Melo J. V., Goldman J. M., Cross N. C. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood. 1996 Jun 15;87(12):5213–5217. [PubMed] [Google Scholar]
  49. van der Reijden B. A., van Ommen G. J., Hagemeijer A., Breuning M. H. Acute myelogenous leukemia: a disorder of gene splicing? Leukemia. 1996 Feb;10(2):204–206. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES